Transcatheter Valve Stakeholders Weigh Merits Of Local Vs. National Coverage
This article was originally published in The Gray Sheet
You may also be interested in...
Trans-Mitral Valve Repair Gains Medicare Coverage-With-Evidence Proposal
A new draft national Medicare coverage policy offers to pay for transcatheter mitral valve repair procedures with devices like Abbott’s MitraClip only if they are conducted by a qualified heart team and are part of a national registry.
Transcatheter Valve Coverage Proposal Reflects Stricter Medicare Environment
CMS’ proposed national coverage determination comes only three months after the approval and launch of Edwards Lifesciences’ Sapien, the first transcatheter aortic valve in the U.S. It restricts coverage to FDA-approved indications and includes a coverage-with-evidence-development provision.
Reimbursement In Brief
Latest news from the Medicare agency and other payers.